Takao Takeshima

Tominaga hospital

H指数:45

被引数:6,177

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal Changes in Brain Volume and Magnetic Susceptibility Following CGRP Monoclonal Antibody Treatment in Patients With Migraine

偏头痛患者接受CGRP单克隆抗体治疗后脑容积和磁化率的纵向变化

Acta Neurologica Scandinavica

IF2.7

2026-09-220

OAAI

Clinical Spectrum of Reversible Cerebral Vasoconstriction Syndrome With and Without Angiographic Vasoconstriction: A Retrospective Study of 84 Hospitalized Patients

可逆性脑血管痉挛综合征的临床谱：伴有和不伴有血管造影血管痉挛的84例住院患者的回顾性研究

Brain and Behavior

IF2.7

2026-09-200

OAAI

Brain Iron Accumulation in Chronic Migraine: Pathophysiological Insights and Imaging Biomarkers for Personalized Therapy

慢性偏头痛中的脑铁累积：个性化疗法的病理生理学见解和成像生物标志物

Acta Neurologica Scandinavica

IF2.7

2026-07-060

OAAI

Effectiveness of Galcanezumab and Traditional Oral Migraine Preventive Medications: Interim 3-Month Japan Subgroup Findings from the TRIUMPH Study

Galcanezumab与传统口服偏头痛预防药物的有效性：TRIUMPH研究中日本亚组3个月中期研究结果

Advances in Therapy

IF4

2026-04-220

OAAI

Local patient-centered headache advocacy with regional and global impact: lessons from the Japanese Patient Advocacy Coalition (JPAC)

本地以患者为中心的头痛倡导活动，具有区域和全球影响：来自日本患者倡导联盟（JPAC）的经验

The Journal of Headache and Pain

IF7.9

2026-02-230

OAAI

Long-term tolerability and effectiveness of eptinezumab in Japanese adults with chronic migraine: results of the 60-week open-label SUNSET trial

日本慢性偏头痛成人患者中依普尼扎木的长期耐受性与有效性：SUNSET试验60周开放标签研究的结果

The Journal of Headache and Pain

IF7.9

2025-11-230

OAAI

Plain Language Summary Publication: Efficacy and safety of rimegepant for the preventive treatment of migraine in Japan: A double-blind, randomized controlled trial

HEADACHE

IF4

2025-11-010

PRE

Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial

Eptinezumab在以亚洲人群为主的慢性偏头痛患者中的有效性与安全性：随机、双盲、安慰剂对照SUNRISE试验的结果

Cephalalgia

IF4.6

2025-10-150

Bilateral Cluster Headache-like Attack as a Manifestation of Reversible Cerebral Vasoconstriction Syndrome Following Carotid Artery Stenting: A Case Report

颈动脉支架置入术后可逆性脑血管收缩综合征表现为双侧丛集性头痛样发作：病例报告

INTERNAL MEDICINE

IF1.1

2025-10-010

OAAI

Atogepant for the preventive treatment of episodic migraine in Japanese participants: A phase 2/3, randomized, double-blind, placebo-controlled trial with an active treatment extension (RELEASE)

阿托格匹兰特用于日本受试者偏头痛发作的预防性治疗：一项2/3期、随机、双盲、安慰剂对照试验，并设活性药物治疗扩展（RELEASE）

Cephalalgia

IF4.6

2025-09-260

Expanding the Genetic and Clinical Spectrum of SCN1A-Related Hemiplegic Migraine: Analysis of Mutations in Japanese

扩展SCN1A相关偏瘫性偏头痛的遗传和临床谱：日本患者突变分析

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF4.9

2025-02-080

Novel and reappraised wide-band EEG findings in migraineurs: Its correlation with several clinical variables

CLINICAL NEUROPHYSIOLOGY

IF3.6

2024-10-010

PRE

A Discrete-Choice Experiment Assessing the Patient Preferences and Real-World Experiences of Patients with Migraine in Japan

NEUROLOGY AND THERAPY

IF4.8

2024-09-301

OAAI

Efficacy of galcanezumab in migraine central sensitizatio

SCIENTIFIC REPORTS

IF3.9

2024-09-182

OAAI

Preliminary External Validation Results of the Artificial Intelligence-Based Headache Diagnostic Model: A Multicenter Prospective Observational Study

LIFE-BASEL

IF3.4

2024-06-110

OAAI

Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study

NEUROLOGY AND THERAPY

IF4.8

2024-04-061

OAAI

Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial

JOURNAL OF HEADACHE AND PAIN

IF7.9

2024-03-253

OAAI

CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society

JOURNAL OF HEADACHE AND PAIN

IF7.9

2024-03-153

OAAI

The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders

世界卫生组织关于癫痫和其他神经系统疾病和头痛革命的部门间全球行动计划: 从头痛负担到头痛疾病的全球行动计划

JOURNAL OF HEADACHE AND PAIN

IF7.9

2024-01-0415

OAAI

Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) Study

NEUROLOGY AND THERAPY

IF4.8

2024-01-041

OAAI

Takao Takeshima

个人简介

教育背景

工作经历

荣誉奖项

研究方向